PT Millennium Pharmacon International Tbk
SDPC
Rank in Stocks
#27752
PT Millennium Pharmacon International Tbk is an Indonesian enterprise... PT Millennium Pharmacon International Tbk is an Indonesian enterprise specializing in the wholesale and provision of a diverse range of healthcare products. This includes both prescription and over-the-counter medicines, nutritional supplements, and medical equipment. The company's comprehensive distribution channels extend to various points of sale, such as retail pharmacies, hospitals, supermarkets, and other retail establishments. As of December 31, 2021, it managed 33 regional offices strategically located across Indonesia's major islands, including Java, Bali, Sumatera, Kalimantan, and Sulawesi. Founded in 1952, the organization was originally known as PT NVPD Soedarpo Corporation Tbk before adopting its current designation, PT Millennium Pharmacon International Tbk, in February 1990. Its corporate headquarters are situated in Jakarta Selatan, Indonesia, and it operates as a subsidiary of Pharmaniaga International Corporation Sdn. Bhd.
Share Price
$0.01074658
Last synced: 2026-11-10
Market Cap
$13.69M
Change (1 day)
7.78%
Change (1 year)
31.01%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Millennium Pharmacon International Tbk (SDPC)
Category
Healthcare
Operating Margin for PT Millennium Pharmacon International Tbk (SDPC)
Operating Margin as of November 2026 TTM: 3.14%
According to PT Millennium Pharmacon International Tbk's latest financial reports, its current operating margin (TTM) is 3.14%. At the end of 2025 the company had an operating margin of 3.15%.
Operating Margin history for PT Millennium Pharmacon International Tbk from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 3.14% | -0.32% |
| 2025 | 3.15% | 28.05% |
| 2024 | 2.46% | -21.41% |
| 2023 | 3.13% | 35.50% |
| 2022 | 2.31% | 19.69% |
| 2021 | 1.93% | -3.50% |
| 2020 | 2.00% | -15.97% |
| 2019 | 2.38% | -10.53% |
| 2018 | 2.66% | 13.68% |
| 2017 | 2.34% | -3.70% |
| 2016 | 2.43% | -2.41% |
| 2015 | 2.49% | 12.16% |
| 2014 | 2.22% | 0.45% |
| 2013 | 2.21% | 12.76% |
| 2012 | 1.96% | 12.64% |
| 2011 | 1.74% | 12.26% |
| 2010 | 1.55% | -46.92% |
| 2009 | 2.92% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -99.48% |
US
|
|
| 1.30% | -99.59% |
US
|
|
| 1.03% | -99.67% |
US
|
|
| 0.91% | -99.71% |
US
|
|
| 9.21% | -97.07% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PT Millennium Pharmacon International Tbk's operating margin
What is PT Millennium Pharmacon International Tbk's operating margin?
PT Millennium Pharmacon International Tbk's operating margin is 3.14%, as of Nov 2026.
What was PT Millennium Pharmacon International Tbk's operating margin in 2025?
In 2025, PT Millennium Pharmacon International Tbk's operating margin was 3.15%, compared with 2.46% in 2024.
How has PT Millennium Pharmacon International Tbk's operating margin changed since 2020?
From 2020 to 2025, PT Millennium Pharmacon International Tbk's operating margin was highest in 2025 (3.15%) and lowest in 2021 (1.93%).
How does PT Millennium Pharmacon International Tbk's operating margin compare with similar companies?
PT Millennium Pharmacon International Tbk's operating margin (3.14%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.